Clinical trial Recruiting at 1 site Interventional Ages 20 to 50 Men only

Investigating how oxytocin affects blood sugar levels

Official title: The Role of Oxytocin in Regulating Blood Glucose

Run by University Hospital, Gentofte, Copenhagen · NCT06334172 · Data updated 2026-11-12

This study is testing whether oxytocin can affect blood sugar levels and hormone release in healthy men with a normal weight.

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexMen only
Enrollment20 (estimated)
SponsorUniversity Hospital, Gentofte, Copenhagen
Academic / other
Locations1 site (Hellerup, Capital Region)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 4, 2024
Trial IDNCT06334172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy men with a body mass index between 19 and 25 kg/m2.

Probably not a fit

Patients with diabetes or significant health issues such as heart, liver, or kidney disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the impact of oxytocin on insulin and glucagon secretion in healthy men with a body mass index under 27 kg/m2. Participants will undergo a graded glucose infusion test while receiving either synthetic oxytocin or a placebo in a randomized, double-blinded manner. The research aims to determine how oxytocin influences glucose-stimulated hormone secretion and will also measure changes in various metabolic markers.

Why it matters

Potential benefit: If successful, this study could lead to new treatments for glucose metabolism disorders, potentially improving blood sugar regulation.

How similar studies have gone: While the role of oxytocin in glucose metabolism is being explored, this specific approach is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI 19-25 kg/m2

Exclusion Criteria:

* Diabetes
* Heart-, liver or kidney disease
* More than 14 units of alcohol weekly, or drug abuse
* Smoking or any kind of nicotine products
* Alanin aminotransferase (ALAT) ≥ 2 × normal range
* Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1,73m2 or creatinine above normal range
* Blood pressure \> 140/90
* Hemoglobin \< normal range
* Corrected QT Interval (Qtc) \>0,45 sec. at electrocardiogram (ECG) at screening
* Known disease in the pituitary gland or previous pituitary surgery
* Any other disease/condition which the trial managers believe may affect participation in the trial

Where it's running

  • Center for Clinical Metabolic Research, Gentofte Hospital
    Hellerup, Capital Region, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.